Target intelligence / Profile preview

Alpha-globin locus (HBA locus)

Target
HBA locus
Molecular classification
Genomic locus, Gene cluster
01

Overview

The alpha-globin locus is a critical genomic region located on chromosome 16 (16p13.3) that contains the HBA1 and HBA2 genes, which are responsible for encoding the alpha-globin subunits of human hemoglobin. In healthy hematopoietic stem and progenitor cells (HSPCs), the expression of this locus is tightly regulated to maintain a 1:1 stoichiometric ratio with beta-globin chains, ensuring the formation of stable hemoglobin tetramers. In the context of beta-thalassemia, a deficiency in beta-globin leads to a relative excess of alpha-globin chains, which precipitate and cause oxidative damage to erythroid precursors, resulting in ineffective erythropoiesis. Consequently, the alpha-globin locus has become a primary target for therapeutic gene editing; by downregulating alpha-globin production through the disruption of the genes or their distal enhancers (such as MCS-R2), researchers aim to restore the globin balance and alleviate disease symptoms. Current experimental approaches utilize advanced genetic tools like CRISPR-Cas9 and base editors to modify patient-derived HSPCs ex vivo before re-infusion. This strategy represents a promising curative pathway for patients with severe hemoglobinopathies by improving the survival and functionality of mature red blood cells.

Other names
HBA1/HBA2 gene clusterHemoglobin subunit alpha locus16p13.3 locusAlpha-globin gene clusterHBZ-HBM-HBA2-HBA1-HBQ1 cluster
02

Mechanism of action

Reduction of alpha-globin chain synthesis via gene disruption or enhancer deletion to mitigate alpha/beta-globin chain imbalance in beta-thalassemia, or restoration of alpha-globin expression via gene addition/correction in alpha-thalassemia.

03

Biological functions

Hemoglobin biosynthesisOxygen transportErythrocyte maturationErythropoiesis
04

Disease associations

Alpha-thalassemiaBeta-thalassemiaHemoglobinopathy
05

Safety considerations

Off-target genomic editingGenotoxicityClonal hematopoiesisPotential for excessive alpha-globin reduction leading to alpha-thalassemia phenotypeInsertional mutagenesis (if using viral vectors)
06

Interacting drugs

CRISPR-Cas9 (experimental)

3 more in the full profile.

07

Biomarkers

Alpha/beta-globin chain ratioHemoglobin A (HbA) levelsMean corpuscular volume (MCV)Reticulocyte countFetal hemoglobin (HbF) levels

Beyond the preview

Go deeper on Alpha-globin locus (HBA locus).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alpha-globin locus (HBA locus).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call